Consistent with the proposed role of the FGF-2/KDM2B-EZH2/miR-101/EZH2 pathway in bladder cancer,11 were data we obtained by analyzing publicly available data sets in Oncomine.20–22 These data show that KDM2B is expressed at higher levels in bladder cancer than in the normal urothelium (Figure 5b). The gene discussed is EZH2; the disease is urinary bladder carcinoma.